drugset
drugset / Trial / NCT01598337

The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency

NCT01598337 ↗

Phase 3 Unknown 200 enrolled Prince Sultan Cardiac Center, Adult Cardiology Department.
RandomizedParallel-groupOpen-labelTreatment

Summary

This protocol is designed to evaluate the effect of antiplatelets (Tirafiban and Prasugrel) on the incidence of early and intermediate graft patency after CABG.

Timeline

Start
2011-04
Primary completion
2013-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg —
Subject Clopidogrel Small molecule 75 mg Oral
Subject Prasugrel Small molecule 10 mg —
Subject Tirofiban Other / unclassified — —

Indications

coronary artery disorder